NCT01525615 - A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD | Biotech Hunter

Enrollment

404

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE

Respimat inhaler

DRUG

tiotropium+olodaterol (low dose)

2.5 µg tiotropium + 5 µg olodaterol

DRUG

tiotropium + olodaterol (high dose)

5 µg tiotropium + 5 µg olodaterol

DEVICE

Respimat inhaler

DEVICE

Respimat inhaler

DRUG

placebo to tiotropium+olodaterol

comparator

Trial Locations (60)

Unknown

1237.15.01503 Boehringer Ingelheim Investigational Site, Torrance

1237.15.01512 Boehringer Ingelheim Investigational Site, Hartford

1237.15.01506 Boehringer Ingelheim Investigational Site, Springfield

1237.15.01507 Boehringer Ingelheim Investigational Site, Iowa City

1237.15.01504 Boehringer Ingelheim Investigational Site, Livonia

1237.15.01511 Boehringer Ingelheim Investigational Site, Saint Charles

1237.15.01509 Boehringer Ingelheim Investigational Site, Lebanon

1237.15.01513 Boehringer Ingelheim Investigational Site, Charlotte

1237.15.01514 Boehringer Ingelheim Investigational Site, Philadelphia

1237.15.01516 Boehringer Ingelheim Investigational Site, Pittsburgh

1237.15.01508 Boehringer Ingelheim Investigational Site, Easley

1237.15.01501 Boehringer Ingelheim Investigational Site, Greenville

1237.15.01505 Boehringer Ingelheim Investigational Site, Spartanburg

1237.15.01502 Boehringer Ingelheim Investigational Site, Union

1237.15.01510 Boehringer Ingelheim Investigational Site, Richmond

1237.15.54502 Boehringer Ingelheim Investigational Site, Buenos Aires

1237.15.54501 Boehringer Ingelheim Investigational Site, Mendonza

1237.15.54503 Boehringer Ingelheim Investigational Site, Provincia de Buenos Aires

1237.15.11501 Boehringer Ingelheim Investigational Site, Hamilotn

1237.15.11503 Boehringer Ingelheim Investigational Site, Hamilton

1237.15.11504 Boehringer Ingelheim Investigational Site, Kingston

1237.15.11505 Boehringer Ingelheim Investigational Site, Montreal

1237.15.11502 Boehringer Ingelheim Investigational Site, Ste-Foy

1237.15.35851 Boehringer Ingelheim Investigational Site, Helsinki

1237.15.35853 Boehringer Ingelheim Investigational Site, Turku

1237.15.35852 Boehringer Ingelheim Investigational Site, Vaasa

1237.15.33502 Boehringer Ingelheim Investigational Site, Nîmes

1237.15.33504 Boehringer Ingelheim Investigational Site, Pessac

1237.15.33501 Boehringer Ingelheim Investigational Site, Strasbourg

1237.15.49507 Boehringer Ingelheim Investigational Site, Aschaffenburg

1237.15.49502 Boehringer Ingelheim Investigational Site, Berlin

1237.15.49504 Boehringer Ingelheim Investigational Site, Berlin

1237.15.49501 Boehringer Ingelheim Investigational Site, Großhansdorf

1237.15.49509 Boehringer Ingelheim Investigational Site, Hamburg

1237.15.49505 Boehringer Ingelheim Investigational Site, Hanover

1237.15.49508 Boehringer Ingelheim Investigational Site, Koblenz

1237.15.49506 Boehringer Ingelheim Investigational Site, Wiesloch

1237.15.36504 Boehringer Ingelheim Investigational Site, Budapest

1237.15.36501 Boehringer Ingelheim Investigational Site, Deszk

1237.15.36503 Boehringer Ingelheim Investigational Site, Nyíregyháza

1237.15.36502 Boehringer Ingelheim Investigational Site, Pécs

1237.15.39512 Boehringer Ingelheim Investigational Site, Ferrara

1237.15.39504 Boehringer Ingelheim Investigational Site, Parma

1237.15.39503 Boehringer Ingelheim Investigational Site, Pavia

1237.15.39501 Boehringer Ingelheim Investigational Site, Pisa

1237.15.39509 Boehringer Ingelheim Investigational Site, Pisa

1237.15.39511 Boehringer Ingelheim Investigational Site, Roma

1237.15.39508 Boehringer Ingelheim Investigational Site, Sesto San Giovanni (MI)

1237.15.39506 Boehringer Ingelheim Investigational Site, Trieste

1237.15.34506 Boehringer Ingelheim Investigational Site, Alicante

1237.15.34501 Boehringer Ingelheim Investigational Site, Barakaldo (Bilbao)

1237.15.34507 Boehringer Ingelheim Investigational Site, Madrid

1237.15.34009 Boehringer Ingelheim Investigational Site, Málaga

1237.15.34001 Boehringer Ingelheim Investigational Site, Santander

1237.15.44152 Boehringer Ingelheim Investigational Site, Leicester

1237.15.44154 Boehringer Ingelheim Investigational Site, Liverpool

1237.15.44153 Boehringer Ingelheim Investigational Site, London

1237.15.44151 Boehringer Ingelheim Investigational Site, Manchester

1237.15.44155 Boehringer Ingelheim Investigational Site, Norwich

1237.15.44158 Boehringer Ingelheim Investigational Site, Plymouth